4
Changes in Ownership
Vistagen Therapeutics, Inc. Filed Acc 0001415889-16-004782
CHIEF EXECUTIVE OFFICER acquired 5,625 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Singh Shawn CHIEF EXECUTIVE OFFICER | 2016-02-12 | Grant or award | +5,625 | 26,234 | I | ||
| Derivatives | |||||||
| Singh Shawn CHIEF EXECUTIVE OFFICER | 2016-02-12 | Returned to the company · Warrant | −2,500 | 0 | I | ||
| Singh Shawn CHIEF EXECUTIVE OFFICER | 2016-02-12 | Returned to the company · Warrant | −5,000 | 0 | I | ||
Loading xslF345X03/form4-02162016_040201.xml…